Am J Transplant, Volume 22, Suppl 3 Archives - Page 182 of 190 - ATC Abstracts

2022 American Transplant Congress
Long-Term Follow Up of Solid Organ Transplantation Using Hepatitis C Virus Positive Donor for Hepatitis C Virus Negative Recipients
H. Sogawa¹, I. Lee², K. Okumura³, R. Bodin⁴, D. C. Wolf⁴, B. Partiula⁴, A. Dhand⁴, M. Kai⁵, S. Ohira⁵, R. Misawa¹, G. Veillette⁶, D. John¹, S. Nishida⁷, T. Diflo⁶
¹Division of Intra-abdominal Organ Transplant, Department of Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, ²Department of Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, ³Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY, ⁴Department of Medicine, Westchester Medical Center/ New York Medical College, Valhalla, NY, ⁵Cardiothoracic Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, ⁶Westchester Medical Center, Valhalla, NY, ⁷Westchester Medical Center/ New York Medical College, Valhalla, NY
*Purpose: To determine the effects of transplanting an HCV + solid organ to an uninfected patient who is on the transplant waiting list. Outcomes include…
2022 American Transplant Congress
Transplantation of Hepatitis C Viremic Donor Organs to Hepatitis C Nonviremic Recipients: A Retrospective Review
M. Leick, M. Blaha, M. Henry
Nebraska Medicine, Omaha, NE
*Purpose: The advent of combination direct-acting antiviral (DAA) agents has improved the ability to treat hepatitis C virus (HCV) infections. As a result, utilization of…
2022 American Transplant Congress
Hepatitis C Positive Kidney Transplant Into Hepatitis C Negative Recipients
R. Savilla¹, A. Ricketts¹, S. A. Deslich², S. Vaishnav¹, J. B. Africa¹, S. Nagaraju¹
¹Renal Transplant, Charleston Area Medical Center, Charleston, WV, ²Research Associate Senior, Health Services & Outcomes Rsc, Charleston Area Medical Center, Charleston, WV
*Purpose: Kidney transplantation is the treatment of choice in end stage renal disease (ESRD). In 2018, 5% to 8% of eligible adults died while on…
2022 American Transplant Congress
Risk for Loss of Hepatitis B Surface Antibody or Hepatitis B Reactivation in Kidney Transplant Recipients Receiving Lymphocyte Depleting Induction
K. Paplaczyk¹, C. Kane¹, M. Kapugi¹, K. Lang¹, K. Cunningham¹, C. D'Agostino¹, J. Boike²
¹Pharmacy, Northwestern Memorial Hospital, Chicago, IL, ²Transplant Hepatology, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Although used in over 60% of kidney transplant recipients, the impact of lymphocyte depleting induction on hepatitis B surface antibody (HBsAb) and hepatitis B…
2022 American Transplant Congress
Donor-Derived Cell-Free DNA (dd-cfDNA) for Assessment of Response After Treatment of Allograft Rejection
R. Gohh¹, J. Klein², M. Jagadeesan³, V. Rao⁴, M. Weir⁵, H. Gilligan⁶, G. Shekhtman⁷, N. Agrawal⁸, Y. Fu⁹, E. Akalin¹⁰
¹Alpert School of Medicine, Brown University, Providence, RI, ²University of Kansas Medical Center, Kansas City, KS, ³George Washington School of Medicine, Washington, DC, ⁴Medical University of South Carolina, Charleston, SC, ⁵University of Maryland, Baltimore, MD, ⁶Massachusetts General Hospital, Boston, MA, ⁷CareDx Inc., Brisbane, CA, ⁸CareDx Inc, Brisbane, CA, ⁹CareDx, Brisbane, CA, ¹⁰Montefiore Medical Center, Bronx, NY
*Purpose: Surveillance of dd-cfDNA after therapy for rejection represents a promising strategy for monitoring post-treatment response. We assessed post-rejection kinetics of dd-cfDNA among kidney transplant…
2022 American Transplant Congress
Glomerular Filtration Rates (GFR) Reference Values for Living Kidney Donors Using the 2021 CKD-EPI Equation without the Race Factor
A. Liaqat, L. Cholin, H. Sawaf, S. Arrigain, J. Augustine, J. Schold, E. Poggio
Cleveland Clinic, Cleveland, OH
*Purpose: Kidney function is central to donor evaluation and KDIGO guidelines recommend using estimated GFR (eGFR) for initial screening. A new creatinine-based CKD-EPI equation ('21…
2022 American Transplant Congress
Phenotypes of Non-Citizen Kidney Transplant Recipients in the United States by Machine Learning Consensus Clustering
P. Vaitla¹, C. Thongprayoon², C. Jadlowiec³, N. Leeaphorn⁴, S. Mao², M. Mao², A. Prakrati⁵, M. Cooper⁶, W. Cheungpasitporn²
¹University of Mississippi Medical Center, Jackson, MS, ²Mayo Clinic, Rochestor, MN, ³Mayo Clinic, Phoenix, AZ, ⁴Saint Luke, Kansas City, MO, ⁵Texas Tech, El Paso, TX, ⁶Georgetown Transplant Institute, Washington, DC
*Purpose: Health care policies and coverage for non-US citizens vary significantly across the country. Kidney transplant outcomes in non-US citizens are at par or better…
2022 American Transplant Congress
Telemedical Surveillance and Optimized Treatment of Blood Pressure in Kidney Transplant Recipients
W. Düttmann¹, M. G. Naik¹, B. Zukunft¹, B. Osmanodja¹, G. Eleftheriadis¹, S. Ronicke², M. Choi¹, F. Bachmann¹, F. Halleck¹, K. Budde¹
¹Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany, ²Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany
*Purpose: Patients with chronic kidney disease suffer often from cardiovascular diseases, especially high blood pressure and its complications such as stroke and heart attack. After…
2022 American Transplant Congress
The Gift of Life: Gift Discourse in Transplant and Its Implications in Anonymous Living Liver Donation
S. S. Humar¹, J. Jung², S. Krause¹, N. Selzner¹, S. Abbey¹
¹University Health Network, Toronto, ON, Canada, ²The Hospital for Sick Children, Toronto, ON, Canada
*Purpose: The Gift of Life metaphor is prevalent in pro-donation dialogue, aiming to promote transplant programs and conceptualize the act of organ donation. To obtain…
2022 American Transplant Congress
Steroid-Free Living Donor Liver Transplantation Using Rabbit Antithymocyte Globulin Induction Reduces Incidence of Acute Cellular Rejection
C. Eymard¹, S. Naik¹, J. Eason²
¹James D Eason Transplant Institute, Memphis, TN, ²University of Tennessee/Methodist Transplant Institute, Memphis, TN
*Purpose: The efficacy of steroid-free immunosuppression protocols using rabbit antithymocyte globulin (RATG) induction with tacrolimus minimization has previously been described in deceased donor liver transplantation.…